Volume 40, Issue 7

Search all Medical Oncology articles

July 2023

28 articles in this issue

Identification of glycogen phosphorylase L as a potential target for lung cancer
Xin-Ling He
Wen-Yu Lyu
Jin-Jian Lu
Original Paper 22 June 2023 Article: 211
Racial and regional disparities in deaths in breast cancer
Akshita Khosla
Devashish Desai
Rashmika Potdar
Original Paper 22 June 2023 Article: 210
The application of radiofrequency ablation in pancreatic cancer liver-only recurrence after radical pancreatectomy
Chengfang Wang
Linjie Song
Weilin Wang
Original Paper 22 June 2023 Article: 209
RUNX1/ETO regulates reactive oxygen species (ROS) levels in t(8,21) acute myeloid leukaemia via FLT3 and RAC1
Adam Azlan
Kang Zi Khor
Emmanuel Jairaj Moses
Original Paper 21 June 2023 Article: 208
Current advances in microbial-based cancer therapies
Areej Shahbaz
Tehreem Mahmood
Bilal Haider Abbasi
Review Article 18 June 2023 Article: 207
NK cells direct the perspective approaches to cancer immunotherapy
Abduladheem Turki Jalil
Mohanad Ali Abdulhadi
Ali A. Fadhil
Review Article 15 June 2023 Article: 206
Current perspectives on Vaxinia virus: an immuno-oncolytic vector in cancer therapy
Simran Deep Kaur
Aman Deep Singh
Deepak N. Kapoor
Perspectives in Oncology 15 June 2023 Article: 205
Circulating cancer giant cells with unique characteristics frequently found in patients with myelodysplastic syndromes (MDS)
Abdullah Mahmood Ali
Fatima BenMohamed
Patrizia Paterlini Bréchot
Original Paper Open access 14 June 2023 Article: 204
Efficacy and safety of EGFR inhibitor gefitinib in recurrent or metastatic cervical cancer: a preliminary report
Abhishek Krishna
M. Sathya
Vaishak Jawahar
Original Paper Open access 13 June 2023 Article: 203
A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer
Hina Qayoom
Mustfa Alkhanani
Manzoor A. Mir
Original Paper 12 June 2023 Article: 202
Recent advancement of HDAC inhibitors against breast cancer
Syed Abdulla Mehmood
Kantrol Kumar Sahu
Deepak Kumar
Review Article 09 June 2023 Article: 201
The future of cancer immunotherapy: DNA vaccines leading the way
Aanshi Pandya
Yesha Shah
Mehul R. Chorawala
Review Article 09 June 2023 Article: 200
The crosstalk between ubiquitin-conjugating enzyme E2Q1 and p53 in colorectal cancer: An in vitro analysis
Maryam Rasouli
Sara Khakshournia
Sayed Mohammad Shafiee
Original Paper 09 June 2023 Article: 199
Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study
Manyi Xu
Yue Hao
Zhengbo Song
Original Paper 09 June 2023 Article: 198
Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target
Sourat Darabi
Joanne Xiu
Michael J. Demeure
Original Paper Open access 08 June 2023 Article: 197
Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle
Ecem Turkmen
Fatma Sogutlu
Cigir Biray Avci
Original Paper 07 June 2023 Article: 196
In vitro chemo-preventive efficacy of synthetic progestin Norethindrone in human epithelial ovarian cancer
Anuradha Sharma
Indu Sharma
Original Paper 03 June 2023 Article: 195
Pretreatment of prostate cancer cells with salinomycin and Wnt inhibitor increases the efficacy of cabazitaxel by inducing apoptosis and decreasing cancer stem cells
Riza Serttas
Suat Erdogan
Original Paper 01 June 2023 Article: 194
Dexamethasone enhances venetoclax-induced apoptosis in acute myeloid leukemia cells
Haixia Wang
Junjie Zhou
Jian Ge
Original Paper 01 June 2023 Article: 193
A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
S. Verma
S. Chitikela
P. S. Malik
Original Paper 01 June 2023 Article: 192
Implications of IL-21 in solid tumor therapy
Seyed Hossein Abtahi Eivary
Ramiar Kamal Kheder
Jafar Hajavi
Review Article 30 May 2023 Article: 191
Therapeutic targeting approach on epithelial-mesenchymal plasticity to combat cancer metastasis
Adyasha Bijay Mishra
Sudhansu Sekhar Nishank
Review Article 29 May 2023 Article: 190
βcaryophyllene oxide induces apoptosis and inhibits proliferation of A549 lung cancer cells
Sameh M. Shabana
Nahla S. Gad
Mohamed Amr El-Missiry
Original Paper Open access 26 May 2023 Article: 189
Isorhamnetin exerts anti-tumor activity in DEN + CCl₄-induced HCC mice
Sayanta Sarkar
Abhishek Kumar Das
Parames C. Sil
Original Paper 24 May 2023 Article: 188
Investigation of the TLR4 and IRF3 signaling pathway-mediated effects of monensin in colorectal cancer cells
Mücahit Seçme
Sema Serter Kocoglu
Original Paper 23 May 2023 Article: 187
The past, present, and future of immunotherapy for endometrial adenocarcinoma
Anna C. Jones
Karah H. Brown
Yujiang Fang
Review Article 23 May 2023 Article: 186
Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC)
Nikhil Chandnani
Vedika Shrirang Choudhari
Koustav Sarkar
Original Paper 22 May 2023 Article: 185
Plumbagin binds to epidermal growth factor receptor and mitigate the effects of epidermal growth factor micro-environment in PANC-1 cells
Loganayaki Periyasamy
Bharathi Murugantham
Sridhar Muthusami
Original Paper 20 May 2023 Article: 184

Volume 40, Issue 7

Identification of glycogen phosphorylase L as a potential target for lung cancer

Racial and regional disparities in deaths in breast cancer

The application of radiofrequency ablation in pancreatic cancer liver-only recurrence after radical pancreatectomy

RUNX1/ETO regulates reactive oxygen species (ROS) levels in t(8,21) acute myeloid leukaemia via FLT3 and RAC1

Current advances in microbial-based cancer therapies

NK cells direct the perspective approaches to cancer immunotherapy

Current perspectives on Vaxinia virus: an immuno-oncolytic vector in cancer therapy

Circulating cancer giant cells with unique characteristics frequently found in patients with myelodysplastic syndromes (MDS)

Efficacy and safety of EGFR inhibitor gefitinib in recurrent or metastatic cervical cancer: a preliminary report

A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer

Recent advancement of HDAC inhibitors against breast cancer

The future of cancer immunotherapy: DNA vaccines leading the way

The crosstalk between ubiquitin-conjugating enzyme E2Q1 and p53 in colorectal cancer: An in vitro analysis

Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study

Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target

Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle

In vitro chemo-preventive efficacy of synthetic progestin Norethindrone in human epithelial ovarian cancer

Pretreatment of prostate cancer cells with salinomycin and Wnt inhibitor increases the efficacy of cabazitaxel by inducing apoptosis and decreasing cancer stem cells

Dexamethasone enhances venetoclax-induced apoptosis in acute myeloid leukemia cells

A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)

Implications of IL-21 in solid tumor therapy

Therapeutic targeting approach on epithelial-mesenchymal plasticity to combat cancer metastasis

βcaryophyllene oxide induces apoptosis and inhibits proliferation of A549 lung cancer cells

Isorhamnetin exerts anti-tumor activity in DEN + CCl₄-induced HCC mice

Investigation of the TLR4 and IRF3 signaling pathway-mediated effects of monensin in colorectal cancer cells

The past, present, and future of immunotherapy for endometrial adenocarcinoma

Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC)

Plumbagin binds to epidermal growth factor receptor and mitigate the effects of epidermal growth factor micro-environment in PANC-1 cells

Navigation